Latest stories on AIM
AIM ImmunoTech Stockholders Approve Key Equity Proposals
TipRanks50 · neutralgeneral
AIM ImmunoTech Inc. (AIM) files 8-K
SEC 8-K50 · neutralgeneral
Silver Bullet shifts year end as AIM trading faces suspension
TipRanks32 · bearishgeneral
Gana Media Director Increases Stake with AIM Share Purchase
TipRanks56 · neutralgeneral
AIM ImmunoTech to Present in the Webull Corporate Connect Webinar Series | AIM Stock News
StockTitan56 · neutralgeneral
AIM ImmunoTech Regains NYSE American Listing Compliance
TipRanks59 · neutralgeneral
AIM ImmunoTech Inc. (AIM) files 8-K
SEC 8-K50 · neutralgeneral
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency | AIM Stock News
StockTitan58 · neutralgeneral
AIM ImmunoTech Raises Capital via Registered Direct Offering
TipRanks28 · bearishgeneral
AIM ImmunoTech Updates Bylaws on Shareholder Voting Standards
TipRanks50 · neutralgeneral
AIM ImmunoTech Inc. (AIM) files 8-K
SEC 8-K50 · neutralgeneral
AIM ImmunoTech’s Phase 2 Ampligen-Imfinzi Study Reports Promising Progress in Pancreatic Cancer
MarketChameleon67 · bullishproduct/pr
AIM ImmunoTech announces $2.65M financing priced at-market
Seeking Alpha24 · bearishgeneral
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
Business Insider24 · bearishgeneral
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules | AIM Stock News
StockTitan24 · bearishgeneral
AIM ImmunoTech Inc. (AIM) Discusses Ampligen's Potential Role in Addressing BundiBugyo Ebola Outbreak Transcript
Seeking Alpha56 · neutralproduct/pr
AIM ImmunoTech Highlights Ampligen’s Emerging Ebola Treatment Potential
TipRanks58 · neutralproduct/pr
3 Penny Stocks Drawing Market Attention, 6/2/26
TipRanks55 · neutralgeneral
AIM ImmunoTech Highlights Ampligen’s Ebola Potential After WHO Emergency—Pre-Clinical Data Shows 100% Survival in Study
MarketChameleon63 · neutralproduct/pr